GENE ONLINE|News &
Opinion
Blog

2021-10-12| Special

Are Digital Therapeutics the Next Generation of Medical Products?

by Sahana Shankar
Share To
Technology has made huge strides in not only health monitoring and disease diagnosis but also active therapeutics. It is a fast-growing health sector that has seen investments grow by 40% year on year since 2013.

A wide range of products backed by evidence and peer-reviewed studies are now available to address cognitive disorders like ADHD, autoimmune diseases, insomnia, and psychiatric disorders like schizophrenia. As a result, there is value for consumers (improved outcomes), physicians (real-time monitoring of symptoms), and investors (large market size), which can drive digital therapeutics for more cost-effective solutions in the future.

At the Biofuture conference, a panel consisting of diverse voices based on the broad spectrum of products in the digital therapeutics space discussed the evolution of digital therapeutics, how they serve unmet clinical needs, how they can redefine therapy/medicine in the future, and how to build successful and sustainable business models for the next generation of products.

GO Prime with only $1.49 now

LATEST
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
Partnership to Manufacture Antibiotic to Combat Antimicrobial Resistance
2023-09-25
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Largest Biotech Event of Thailand Takes Center Stage
2023-09-22
BIOHK2023: A Place Where Biotechnology Meets Financial Economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top